pGL3-Enhancer Search name
pGL3-Enhancer,Plasmid pGL3-Enhancer,pGL3-Enhancer vector
pGL3-Enhancer Information
Replicon: pUC ori, F1 ori
Terminator: SV40 poly (A) signal
Plasmid classification: mammalian cells, signal pathway reporting vectors
Plasmid size: 5064bp
Prokaryotic resistance: Amp
Clonal strain: DH5 alpha
Culture conditions: 37 C, aerobic LB
Expression host: lactation cells
Induction mode: no need to induce, transient expression.
5'sequencing primers: RVP3:CTAGCAAAATAGGCTGTCCC
Primers for 3'sequencing: primers designed based on sequences
pGL3-Enhancer Description
The pGL3 Luciferase Reporter Vectors(a–c) provide a basis for the quantitative analysis of factors that potentially regulate mammalian gene expression. These factors may be cis-acting, such as promoters and enhancers, or trans-acting, such as various DNA-binding factors. The backbone of the pGL3 Luciferase Reporter Vectors is designed for increased expression, and contains a modified coding region for firefly (Photinus pyralis) luciferase that has been optimized for monitoring transcriptional activity in transfected eukaryotic cells. The assay of this genetic reporter is rapid, sensitive and quantitative. In addition, these Luciferase Reporter Vectors contain numerous features aiding in the structural characterization of the putative regulatory sequences under investigation.
pGL3-Enhancer Multiple cloning site
pGL3-Enhancer Sequence
LOCUS Exported File 5064 bp ds-DNA circular SYN 23-3-2015
DEFINITION .
ACCESSION .
VERSION .
KEYWORDS Untitled
SOURCE synthetic DNA construct
ORGANISM synthetic DNA construct
REFERENCE 1 (bases 1 to 5064)
AUTHORS .
TITLE Direct Submission
JOURNAL Exported 2015-3-23
FEATURES Location/Qualifiers
source 1..5064
/organism="synthetic DNA construct"
/mol_type="other DNA"
CDS 88..1740
/codon_start=1
/gene="luc+"
/product="firefly luciferase"
/EC_number="
"
/note="luciferase"
/note="enhanced?luc+ version of the luciferase gene"
/protein_id="
"
/translation="MEDAKNIKKGPAPFYPLEDGTAGEQLHKAMKRYALVPGTIAFTDA
HIEVDITYAEYFEMSVRLAEAMKRYGLNTNHRIVVCSENSLQFFMPVLGALFIGVAVAP
ANDIYNERELLNSMGISQPTVVFVSKKGLQKILNVQKKLPIIQKIIIMDSKTDYQGFQS
MYTFVTSHLPPGFNEYDFVPESFDRDKTIALIMNSSGSTGLPKGVALPHRTACVRFSHA
RDPIFGNQIIPDTAILSVVPFHHGFGMFTTLGYLICGFRVVLMYRFEEELFLRSLQDYK
IQSALLVPTLFSFFAKSTLIDKYDLSNLHEIASGGAPLSKEVGEAVAKRFHLPGIRQGY
GLTETTSAILITPEGDDKPGAVGKVVPFFEAKVVDLDTGKTLGVNQRGELCVRGPMIMS
GYVNNPEATNALIDKDGWLHSGDIAYWDEDEHFFIVDRLKSLIKYKGYQVAPAELESIL
LQHPNIFDAGVAGLPDDDAGELPAAVVVLEHGKTMTEKEIVDYVASQVTTAKKLRGGVV
FVDEVPKGLTGKLDARKIREILIKAKKGGKIAV"
polyA_signal 1781..1902
/note="SV40 poly(A) signal"
/note="SV40 polyadenylation signal"
rep_origin complement(2567..3155)
/direction=LEFT
/note="ori"
/note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
replication"
CDS complement(3326..4186)
/codon_start=1
/gene="bla"
/product="beta-lactamase"
/note="AmpR"
/note="confers resistance to ampicillin, carbenicillin, and
related antibiotics"
/translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI
ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYS
PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
EPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA
LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
LIKHW"
promoter complement(4187..4291)
/gene="bla"
/note="AmpR promoter"
rep_origin 4318..4773
/direction=RIGHT
/note="f1 ori"
/note="f1 bacteriophage origin of replication; arrow
indicates direction of (+) strand synthesis"
polyA_signal 4904..4952
/note="synthetic polyadenylation signal"
misc_feature 4966..5057
/note="pause site"
/note="RNA polymerase II transcriptional pause signal from
the human?alpha-2 globin gene"
ORIGIN
1 ggtaccgagc tcttacgcgt gctagcccgg gctcgagatc tgcgatctaa gtaagcttgg
61 cattccggta ctgttggtaa agccaccatg gaagacgcca aaaacataaa gaaaggcccg
121 gcgccattct atccgctgga agatggaacc gctggagagc aactgcataa ggctatgaag
181 agatacgccc tggttcctgg aacaattgct tttacagatg cacatatcga ggtggacatc
241 acttacgctg agtacttcga aatgtccgtt cggttggcag aagctatgaa acgatatggg
301 ctgaatacaa atcacagaat cgtcgtatgc agtgaaaact ctcttcaatt ctttatgccg
361 gtgttgggcg cgttatttat cggagttgca gttgcgcccg cgaacgacat ttataatgaa
421 cgtgaattgc tcaacagtat gggcatttcg cagcctaccg tggtgttcgt ttccaaaaag
481 gggttgcaaa aaattttgaa cgtgcaaaaa aagctcccaa tcatccaaaa aattattatc
541 atggattcta aaacggatta ccagggattt cagtcgatgt acacgttcgt cacatctcat
601 ctacctcccg gttttaatga atacgatttt gtgccagagt ccttcgatag ggacaagaca
661 attgcactga tcatgaactc ctctggatct actggtctgc ctaaaggtgt cgctctgcct
721 catagaactg cctgcgtgag attctcgcat gccagagatc ctatttttgg caatcaaatc
781 attccggata ctgcgatttt aagtgttgtt ccattccatc acggttttgg aatgtttact
841 acactcggat atttgatatg tggatttcga gtcgtcttaa tgtatagatt tgaagaagag
901 ctgtttctga ggagccttca ggattacaag attcaaagtg cgctgctggt gccaacccta
961 ttctccttct tcgccaaaag cactctgatt gacaaatacg atttatctaa tttacacgaa
1021 attgcttctg gtggcgctcc cctctctaag gaagtcgggg aagcggttgc caagaggttc
1081 catctgccag gtatcaggca aggatatggg ctcactgaga ctacatcagc tattctgatt
1141 acacccgagg gggatgataa accgggcgcg gtcggtaaag ttgttccatt ttttgaagcg
1201 aaggttgtgg atctggatac cgggaaaacg ctgggcgtta atcaaagagg cgaactgtgt
1261 gtgagaggtc ctatgattat gtccggttat gtaaacaatc cggaagcgac caacgccttg
1321 attgacaagg atggatggct acattctgga gacatagctt actgggacga agacgaacac
1381 ttcttcatcg ttgaccgcct gaagtctctg attaagtaca aaggctatca ggtggctccc
1441 gctgaattgg aatccatctt gctccaacac cccaacatct tcgacgcagg tgtcgcaggt
1501 cttcccgacg atgacgccgg tgaacttccc gccgccgttg ttgttttgga gcacggaaag
1561 acgatgacgg aaaaagagat cgtggattac gtcgccagtc aagtaacaac cgcgaaaaag
1621 ttgcgcggag gagttgtgtt tgtggacgaa gtaccgaaag gtcttaccgg aaaactcgac
1681 gcaagaaaaa tcagagagat cctcataaag gccaagaagg gcggaaagat cgccgtgtaa
1741 ttctagagtc ggggcggccg gccgcttcga gcagacatga taagatacat tgatgagttt
1801 ggacaaacca caactagaat gcagtgaaaa aaatgcttta tttgtgaaat ttgtgatgct
1861 attgctttat ttgtaaccat tataagctgc aataaacaag ttaacaacaa caattgcatt
温馨提示：不可用于临床ZL。
